EL7.AI
StocksUpdated•Originally published 23 July 2026•Updated 23 July 2026•
1 min read

CME Group Stock Drops 12% in 11 Months Despite Record Revenue and Data Growth

Key Facts

1CME Group reported record Q2 2026 revenue of $1.71 billion.
2Non-GAAP EPS reached $2.99 with an adjusted operating margin of 69.5%.
3The company distributed $1.2 billion to shareholders via dividends and buybacks.

In a move highlighting the divergence between operational success and market performance, CME Group reported record Q2 2026 results fueled by exceptional growth in non-trading services. The company achieved total revenue of $1.71 billion, bolstered by a surge in Market Data revenue exceeding 20% year-over-year, while adjusted earnings per share reached $2.99 with a robust operating margin of 69.5%.

Despite these record figures and the distribution of $1.2 billion to shareholders, the stock faces significant pressure, having declined nearly 12% over the past 11 months and underperforming the S&P 500. Per market data, the 0HR2.L stock closed at $251.33 (close of July 22, 2026), as investors remain cautious despite disciplined expense management and the strong performance of the data segment.

Traders are now watching for potential support levels after the stock fluctuated between $235.01 and $255.11 in recent sessions. Looking ahead, market participants are monitoring global risk appetite following recent macroeconomic catalysts, including Malaysia's 5.8% GDP growth and the EU CPI decline to 2.8% as of July 17, 2026.